Literature DB >> 7930739

Immunocytochemical detection of cytokines in the lymph nodes and brains of mice resistant or susceptible to toxoplasmic encephalitis.

C A Hunter1, M J Litton, J S Remington, J S Abrams.   

Abstract

BALB/c mice develop toxoplasmic encephalitis (TE) but the pathology resolves; in contrast, CBA/Ca mice develop progressive TE. Immunohistochemical analysis revealed peak staining for interferon-gamma (IFN-gamma) and tumor necrosis factor (TNF) in lymph nodes of both strains on day 7 of infection, with elevated levels of IFN-gamma and TNF persisting in CBA/Ca mice. TNF was present in the central nervous systems (CNS) of both strains of mice and correlated with severity of pathology. Interleukin (IL)-2 was detected in lymph nodes and CNS of CBA/Ca mice after day 52 of infection and only in the lymph nodes of BALB/c mice between days 14 and 21 after infection. Highest levels of IL-10 were observed in lymph nodes and CNS of infected CBA/Ca mice. Variations in cytokine levels in lymph nodes and CNS of these mouse strains may account for differences in their susceptibility to TE.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930739     DOI: 10.1093/infdis/170.4.939

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

Review 1.  Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain.

Authors:  Yasuhiro Suzuki; Qila Sa; Marie Gehman; Eri Ochiai
Journal:  Expert Rev Mol Med       Date:  2011-10-04       Impact factor: 5.600

2.  Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia.

Authors:  Claudia Rozenfeld; Rodrigo Martinez; Sérgio Seabra; Celso Sant'anna; J Gabriel R Gonçalves; Marcelo Bozza; Vivaldo Moura-Neto; Wanderley De Souza
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

Review 3.  Effects of Toxoplasma gondii infection on the brain.

Authors:  Vern B Carruthers; Yasuhiro Suzuki
Journal:  Schizophr Bull       Date:  2007-02-23       Impact factor: 9.306

4.  Sleep onset insomnia, daytime sleepiness and sleep duration in relationship to Toxoplasma gondii IgG seropositivity and serointensity.

Authors:  Zaki Ahmad; Yara W Moustafa; John W Stiller; Mary A Pavlovich; Uttam K Raheja; Claudia Gragnoli; Soren Snitker; Sarra Nazem; Aline Dagdag; Beverly Fang; Dietmar Fuchs; Christopher A Lowry; Teodor T Postolache
Journal:  Pteridines       Date:  2017-11-28       Impact factor: 0.581

5.  In vitro investigation of host resistance to Toxoplasma gondii infection in microglia of BALB/c and CBA/Ca mice.

Authors:  Y R Freund; N T Zaveri; H S Javitz
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

6.  Interleukin-10 modulates susceptibility in experimental cerebral malaria.

Authors:  S Kossodo; C Monso; P Juillard; T Velu; M Goldman; G E Grau
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

7.  Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP.

Authors:  S K Halonen; G A Taylor; L M Weiss
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

8.  Different roles for interleukin-4 during the course of Toxoplasma gondii infection.

Authors:  C W Roberts; D J Ferguson; H Jebbari; A Satoskar; H Bluethmann; J Alexander
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Tumor necrosis factor alpha upregulates human microglial cell production of interleukin-10 in vitro.

Authors:  W S Sheng; S Hu; F H Kravitz; P K Peterson; C C Chao
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

10.  Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes.

Authors:  S K Halonen; F Chiu; L M Weiss
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.